Review: taking Xarelto and Aspirin together


Summary

Drug interactions are reported among people who take Xarelto and Aspirin together. This review analyzes the effectiveness and drug interactions between Xarelto and Aspirin. It is created by eHealthMe based on reports of 8,072 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Xarelto

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. (latest outcomes from Xarelto 53,959 users)

Aspirin

Aspirin has active ingredients of aspirin. It is often used in preventive health care. (latest outcomes from Aspirin 272,197 users)

On Sep, 20, 2016

8,072 people who take Xarelto, Aspirin are studied.


Number of reports submitted per year:

Xarelto and Aspirin drug interactions.

Drug effectiveness over time:

Xarelto:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Aspirin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 25.0% - (1 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Xarelto:
  • female: 33.0% - (1 of 3 people)
  • male: 75.0% - (3 of 4 people)
Aspirin:
  • female: 20.0% - (1 of 5 people)
  • male: 66.0% - (4 of 6 people)

Drug effectiveness by age:

Xarelto:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 66.0% - (4 of 6 people)
Aspirin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (5 of 10 people)

Most common drug interactions over time *:

< 1 month:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • epistaxis
  • haematuria
  • haemoglobin decreased
  • haemorrhage
  • lower gastrointestinal haemorrhage
1 - 6 months:
  • gastrointestinal haemorrhage
  • anaemia
  • rectal haemorrhage
  • haemorrhagic anaemia
  • epistaxis
  • upper gastrointestinal haemorrhage
  • haematuria
  • haemorrhage
  • lower gastrointestinal haemorrhage
  • cerebral haemorrhage
6 - 12 months:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • epistaxis
  • haematuria
  • cerebral haemorrhage
  • lower gastrointestinal haemorrhage
  • haematoma
1 - 2 years:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • epistaxis
  • anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • haematuria
  • cerebral haemorrhage
  • lower gastrointestinal haemorrhage
  • respiratory failure
2 - 5 years:
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • epistaxis
  • rectal haemorrhage
  • anaemia
  • upper gastrointestinal haemorrhage
  • respiratory failure
  • cerebral haemorrhage
  • deep vein thrombosis
  • haemorrhagic stroke
5 - 10 years:
  • gastrointestinal haemorrhage
  • anaemia
  • abasia
  • accident
  • melaena
  • asthenia
  • asthma
  • atrial fibrillation
  • blood glucose increased
  • cardiomegaly
10+ years:
  • anaemia
  • coagulopathy
  • hypokalaemia
  • interstitial lung disease
  • respiratory failure
  • atrial fibrillation
  • dizziness
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • melaena
not specified:
  • gastrointestinal haemorrhage
  • epistaxis
  • rectal haemorrhage
  • anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • haemorrhage
  • haematuria
  • haemoglobin decreased
  • fall

Most common drug interactions by gender *:

female:
  • gastrointestinal haemorrhage
  • anaemia
  • rectal haemorrhage
  • epistaxis
  • haemorrhagic anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhage
  • haemoglobin decreased
  • cerebrovascular accident
  • lower gastrointestinal haemorrhage
male:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • epistaxis
  • anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • haematuria
  • haemorrhage
  • cerebral haemorrhage
  • haemoglobin decreased

Most common drug interactions by age *:

0-1:
  • gastrointestinal haemorrhage
  • haematuria
  • vaginal haemorrhage
10-19:
  • anhedonia
  • anxiety
  • constipation
  • deep vein thrombosis
  • emotional distress
  • fear
  • glaucoma
  • injury
  • intraocular pressure increased
  • macular degeneration
20-29:
  • epistaxis
  • deep vein thrombosis
  • nausea
  • abdominal discomfort
  • abdominal pain
  • cerebral haemorrhage
  • ulcer haemorrhage
  • adverse drug reaction
  • thrombosis
  • varicose vein
30-39:
  • gastrointestinal haemorrhage
  • haemoptysis
  • thrombosis
  • rectal haemorrhage
  • dyspnoea
  • epistaxis
  • depression
  • upper gastrointestinal haemorrhage
  • menorrhagia
  • haematemesis
40-49:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • vaginal haemorrhage
  • anaemia
  • menorrhagia
  • haemorrhagic stroke
  • cerebral haemorrhage
  • thrombosis
  • epistaxis
  • upper gastrointestinal haemorrhage
50-59:
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • epistaxis
  • anaemia
  • haemorrhagic stroke
  • haematuria
  • haemorrhagic anaemia
  • upper gastrointestinal haemorrhage
  • haemorrhage
  • cerebrovascular accident
60+:
  • gastrointestinal haemorrhage
  • anaemia
  • rectal haemorrhage
  • epistaxis
  • haemorrhagic anaemia
  • upper gastrointestinal haemorrhage
  • haematuria
  • haemorrhage
  • haemoglobin decreased
  • cerebral haemorrhage

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Xarelto and Aspirin?

Can you answer these questions?

More questions for: Xarelto, Aspirin

You may be interested in these reviews

More reviews for: Xarelto, Aspirin

On eHealthMe, Xarelto (rivaroxaban) is often used to treat atrial fibrillation/flutter. Aspirin (aspirin) is often used to treat preventive health care. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.